CN Patent
CN107892684B — 喹唑啉衍生物及其药物组合物,以及作为药物的用途
Assigned to Shanghai Fochon Pharmaceutical Co Ltd · Expires 2020-05-26 · 6y expired
What this patent protects
本发明公开了一种蛋白酶抑制剂,尤其是公开了一类新型的喹唑啉衍生物及其药物组合物,以及它们的制备方法和用途。
USPTO Abstract
本发明公开了一种蛋白酶抑制剂,尤其是公开了一类新型的喹唑啉衍生物及其药物组合物,以及它们的制备方法和用途。
Drugs covered by this patent
- Vizimpro (Dacomitinib) · Pfizer Inc.
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.